Goonaseelan (Colin) Pillai is committed to driving programs that develop scientific capability in low and middle-income countries.
A clinical pharmacologist who trained in Durban, South Africa, Colin previously worked at the corporate headquarters of Novartis and Roche in Switzerland. He has a specialist interest in the application of non-linear mixed effects models to pharmacokinetic-pharmacodynamic data across a wide range of therapeutic areas.
In Pharma, he played leadership roles in bringing internal and external acceptance of applying mathematical models to decision making in drug development. His most recent Pharma role involved establishing programs that allowed sharing scientific expertise and infrastructure with researchers and institutions in LMIC.
Colin has held teaching, research and management positions at the Universities of Durban-Westville and Witwatersrand. He acquired his clinical and research experience in hospital and community pharmacy and as a consultant with the SA Medical Research Council’s Tuberculosis Research program, where he ran a unit conducting Phase 1 clinical trials. Colin continues to maintain active academic links with numerous institutions in Africa including via formal Honorary Professorships and Board Member status. Since November 2017, he is a Senior Advisor on capacity development and training programs for global health to the Bill and Melinda Gates Foundation.
Fundisa Academy of Medicines Development
Clinical Pharmacologist, many years experience in clinical drug development in international pharmaceutical industry, former head of the Division of Clinical Pharmacology at Stellenbosch University, visiting scientist at the Charité in Berlin, and President of Fundisa African Academy of Medicines Development which has been established in Cape Town to offer capacity building initiatives in medicines development and regulation in Africa. Vice treasurer of the Manenberg Aftercare Centre in Cape Town, honorary chaplain at the Berlin Airport; resides near Potsdam (Germany).
School for Data Science and Computational Thinking @ Stellenbosch University
Kanshukan Rajaratnam is the Director of the School for Data Science and Computational Thinking and an Associate Professor in the Department of Statistics and Actuarial Science at Stellenbosch University. He holds a doctoral degree in systems engineering from the University of Virginia. Prior to his doctoral studies, he worked in industry – Accenture and Nedbank in South Africa and Capital One in the U.S.A. He then taught finance at the University of Cape Town (UCT) for nine years. At UCT, he held various leadership positions including Acting Dean of the Commerce Faculty.
In the past, his research focus was on the application of data science and operations research in banking and finance. Currently, he is collaborating in research focussing on long covid, vaccine injury, medical ethics, and developing a cross-country database for non-communicable diseases. He is rated by the National Research Foundation as an internationally acclaimed researcher.
I am a researcher working at the intersection of physiology, pharmacology, pharmacometrics, and data science, with an interest in neuroscience when possible. My academic background includes a MSc in Molecular Biology, a PhD in Physiology, and further postgraduate training in pharmacometrics and modelling as an Applied Pharmacometrics Training (APT) fellow. My data analysis and modelling work is primarily conducted in R. I like to reason from a first principles perspective and find myself motivated by all the different problems to solve around me. A multidisciplinary mindset is needed to navigate the possibilities of an open future.
Sunday O. Oladejo
Sunday O. Oladejo received his PhD in Electrical and Electronic Engineering from the University of Cape Town, South Africa, in 2021. He is currently a postdoctoral research fellow at the School for Data Science and Computational Thinking, Stellenbosch University, South Africa. From 2007 to 2017, he was a Senior Core Network Engineer with GloMobile, Nigeria. His research interests include artificial intelligence, swarm intelligence, optimization, computational thinking, data science and analytics. He loves hiking, playing chess, and reading biographies.
Fundisa Academy of Medicines Development
Postdoctoral Research Fellow
Tirhani Maluleke has a PhD in Pharmacology and a Postgraduate Diploma in Pharmaceutical Medicine from the University of Stellenbosch, South Africa. She has more than 17 years of experience in the pharmaceutical industry in various fields including market access, regulatory, and Clinical Trials; with special interest and expertise in regulatory/start-up, compliance and pharmacovigilance. With 7+ yearsâ€™ senior / management role, her duties include training, mentoring and coaching junior colleagues.
She has worked across different pharma companies, CROs and the South African Health Products Regulatory Authority (formerly, Medicines Control Council).
Outside her professional role, she has been involved in various community building projects which mainly focused on mentoring, training and upskilling young people in townships and rural areas.
In the midst of a seemingly infinite landscape of soulless, dull, and otherwise unqualified operators, there is still hope. Here is a person who knows the fine line between rock-solid management and improvised genius. He knows the difference between good and evil, and isn’t afraid to use both to get the job done. For him, breakfast comes with a dose of unfettered creative energy and dinner is served with the satisfaction of a job well done. Does this sound too good to be true?
Think again – you’re reading his bio.
University of Liverpool / Infectious Diseases Institute Makerere University
Professor of Clinical Pharmacology and Global Health
Catriona Waitt is a Professor of Clinical Pharmacology and Global Health at the University of Liverpool, UK, and is undertaking her Wellcome Clinical Research Career Development Fellow at the Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. Her major interest is drug dosing and safety in populations who are complex and often neglected from clinical trials, particularly pregnant and breastfeeding mothers and their infants. She brings together clinical trials, pharmacokinetic modelling, bioanalysis, bioethics and community engagement, and is a member of the Scientific Advisory Board for Pharmacometrics Africa. She loves to think outside the box and break silos between disciplines and sectors.
Charité Universitätsmedizin Berlin
Consultant Anesthesiology / Intensive Care Medicine
Dr. Karin Steinecke
Karin Steinecke undertook her medical studies at Otto von Guericke University Magdeburg from 1998 to 2004. Subsequently, from 2004 to 2017, she got trained as an anaesthesiologist, primarily specializing in intensive care medicine, working as a senior physician at the ICU. In 2017, she transitioned to Charité Berlin, joining the Clinic for Anaesthesiology and Intensive Care Medicine CCM/CVK, where she currently holds the position of a senior aphysician in intensive care medicine and the outpatient department for post-intensive care patients. Since 2018, she has been an integral part of the tele-intensive care team and actively contributed to the establishment of a telemedicine network in the Berlin/Brandenburg region. During the COVID-19 pandemic, Dr. Steinecke played a crucial role in developing and overseeing international telemedicine collaborations and projects. Her responsibilities included fostering partnerships with various countries such as Uzbekistan, Uganda, Ukraine, South Africa, Montenegro, and Israel. Particularly noteworthy was her achievement in facilitating knowledge transfer through educational initiatives and training programs supported by telemedicine. Since 2024, Dr. Steinecke has received funding from Stiftung Charité as a Clinical Fellow, focusing on the topic of “Consolidation of an international hospital network to establish a structured, telemedicine-assisted training curriculum for intensive care medicine (TEMPERA).”
Just give us your email address and we’ll let you know when registration is open. If you’d like, we’ll add you to our mailing list so you stay up to date on what’s happening at Digital Health Africa 2024
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.